Nuvo Pharmaceuticals Inc NRIFF

Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc

Bullboard Posts

Comment by consultant99on Aug 29, 2017 3:48pm

207 Views

Post# 26633944

RE:RE:RE:CTX

Market cap is shares outstanding x market price for the shares.

Book value includes cash + the value of assets purchased less depreciation

When the market cap is below the book value it has implications for a stock.
If a company is losing money the book value will erode by the continuation of the losses.
If the market does not believe the assets are worth what management paid they will only buy shares at a discount to book.

How come insiders are not buying this stock instead of creating 1$ warrents?

Insiders are not obligated to buy shares to prop up the share price. That said CTX is trading at a hefty discount to the book value of $1.79/share (as per TD WebBroker). Keep in mind that Crescita has always traded at a discount to book value - even when sitting with over $35 million in cash. Does that not say something?

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages